LIGANDAL
Ligandal is a regenerative medicine and pandemic defense biotechnology company that creates ligands and delivery technologies. We've developed a machine learning approach for the rapid discovery, design and development of novel peptide therapeutics and targeting molecules for nanoscale delivery systems.
li·gand
noun
BIOCHEMISTRY
a molecule that binds to another (usually larger) molecule.
Imagine a world where biology can be reprogrammed with the same ease as your computer. We believe in that world, and want to see the ultimate good for human health and longevity arise from these capabilities.
We use computational biology, machine learning and AI to develop next-generation medicine, bringing you nearly a decade of experience in developing peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, and advanced antidote-vaccine technologies. Our current lead candidate, SARS-BLOCK™, is designed as an early treatment and prophylactic against the virus that causes COVID-19. Additionally, we have numerous discovery-stage programs for the treatment of rare diseases and cancers using our platform.
li·gand
noun
BIOCHEMISTRY
a molecule that binds to another (usually larger) molecule.
Imagine a world where biology can be reprogrammed with the same ease as your computer. We believe in that world, and want to see the ultimate good for human health and longevity arise from these capabilities.
We use computational biology, machine learning and AI to develop next-generation medicine, bringing you nearly a decade of experience in developing peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, and advanced antidote-vaccine technologies. Our current lead candidate, SARS-BLOCK™, is designed as an early treatment and prophylactic against the virus that causes COVID-19. Additionally, we have numerous discovery-stage programs for the treatment of rare diseases and cancers using our platform.
SEE OUR PUBLICATION: PEPTIDE ANTIDOTES TO SARS-COV-2 (COVID-19)
